[1]
“Hexonic derivatives as human GABA-AT inhibitors: A molecular docking approach”, Bangladesh J Pharmacol, vol. 10, no. 1, pp. 1–6, Jan. 2015, doi: 10.3329/bjp.v10i1.20642.